Krish Ramadurai

Krish W. Ramadurai serves as a Partner at AIX Ventures, focusing on investments at the intersection of Healthcare, Life Sciences, and Artificial Intelligence. Ramadurai is also a Venture Mentor with the National Venture Capital Association and a Venture Advisor at Nucleate, where the mission is to empower the next generation of biotech leaders. In addition to these roles, Ramadurai holds a position as a Guest Lecturer at Harvard University, delivering over 25 lectures in Tissue Engineering and Biochemical Engineering. Prior experience includes serving as Chairman of the Board and Investor at PreciPoint, Board Observer and Investor roles at xCures and Sorcero, and investment positions at bit.bio, Attivare Therapeutics, and Caresyntax. Ramadurai holds multiple advanced degrees, including a DPhil in Engineering Science and an MSc in Nanotechnology for Medicine from the University of Oxford, an MBA from Washington University in St. Louis, and a Master's in Biology from Harvard University, along with a Bachelor's in Integrative Biology and Economics from the University of Illinois Urbana-Champaign.